HEALTHY EXTRACTS INC.: Healthy Extracts Sees First Half 2026 Net Revenue Up More Than 93% to Record $3.6 Million+

Healthy Extracts Inc. (OTCQB:HYEX) said it expects Q2 2026 net revenue to exceed $2.0 million, up more than 112% sequentially and 129% year over year. For the first half ended June 30, 2026, it expects net revenue above $3.6 million, up over 93% from H1 2025, citing the Gummy USA merger and the Imaraïs Beauty acquisition.

Original reporting
Published Aug 6, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 1:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$HYEX
Bullish
medium confidence
Mentioned
$HYEX
Relevance
7/10
AlphAI data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$HYEXBullishMed
01

Why it matters

The main tradable element is forward-looking revenue guidance for Q2 and first-half 2026, plus operational detail on a nearly 4 million gummy initial order and shipping to 4,000+ store locations, both attributed to the Imaraïs integration.

02

Market read

For HYEX, the article provides specific revenue targets and ties them to newly acquired/partnered product lines and retail distribution momentum, which can influence near-term sentiment and positioning ahead of reported results.

03

What to watch

The piece does not quantify gross margin, cash burn, working-capital needs, or integration costs from the Gummy USA merger and Imaraïs acquisition, which are critical for translating topline growth into shareholder value.

Relevance 7/10Novelty 7/10Timing: pre-report guidance for Q2 and first-half ended June 30, 2026

Background

Healthy Extracts is an OTC nutraceutical and precision-dose gummy manufacturer, and the article frames 2026 performance as driven by its October 2025 Gummy USA merger and May 2026 acquisition of Imaraïs Beauty.

Company-level read

Ticker impact

$HYEXBullishMedium confidence
Context

Healthy Extracts (OTCQB:HYEX) guides Q2 net revenue above $2.0M and first-half net revenue above $3.6M, citing the Imaraïs acquisition and Gummy USA merger.

Expected impact

Likely positive bias for HYEX on increased visibility into revenue run-rate, though OTC microcap liquidity and execution risk may limit follow-through.

Evidence & confidence

The text provides concrete forward-looking revenue figures and links them to specific deal milestones (acquisition, manufacturing partnership evolving into acquisition, and a nearly 4M-gummy initial order shipping to 4,000+ locations). However, it is still a forecast/PR rather than audited results, and no valuation or balance-sheet details are provided.

Market effects

Supports the broader nutraceutical and functional gummy manufacturing consolidation theme, highlighting B2B manufacturing scale-up and retail distribution expansion as key growth levers.

Primarily US retail distribution expansion (Target, Ulta, Sprouts) could modestly lift demand for contract manufacturing in the US health and beauty supply chain.

Imaraïs is described as having worldwide retail and online reach, implying potential international distribution upside if execution matches the acquisition thesis.

Counterpoint

Revenue targets may be optimistic given the article’s reliance on deal synergies and an initial order; without confirmation of repeat orders and margins, the guidance could disappoint.

Key entities

  • Healthy Extracts Inc.

    OTCQB:HYEX nutraceutical formulations and precision-dose gummy manufacturing company issuing 2026 revenue outlook and integration updates.

  • Imaraïs Beauty

    Plant-based ingestible beauty and wellness brand founded by Sommer Ray and Aaron Hefter, whose partnership evolved into an acquisition by Healthy Extracts.

  • Gummy USA

    Wholly owned subsidiary of Healthy Extracts referenced as the platform for precision-dosed gummy manufacturing and the October 2025 merger synergy.

  • Sommer Ray

    Media personality associated with Imaraïs Beauty’s founding and brand profile.

  • Aaron Hefter

    Supplement industry veteran associated with Imaraïs Beauty’s founding.

Related articles

$NNVCMed

NanoViricides, Inc. Has Filed its Quarterly Report - Broad-Spectrum Antiviral Drug NV-387 Oral Gummies Has Entered Two Separate Phase II Clinical Trials - One to Treat Ebola Bundibugyo Virus Disease, and Another to Treat Mpox

NanoViricides, Inc. (NYSE American:NNVC) filed its Q3 2026 report, revealing Phase II trials for NV-387 Oral Gummies to treat Ebola and Mpox. The company has $2.98M in cash and $9.56M in total assets, but warns of insufficient funding for operations beyond November 2027.

$UBERMed

Kohl’s products now available for delivery on Uber Eats

Uber (UBER) and Kohl's (KSS) partnered to offer Kohl's products via Uber Eats, covering 1,100+ U.S. stores. Items include apparel, home goods, and Sephora beauty products. The service launches before the holiday season, with a $10 discount on first orders over $50 until December 3, 2026. Kohl's operates 1,100+ stores in 49 states.